Despite advancements in disease understanding and therapeutic interventions, the global burden of diseases continues to increase rapidly, emphasizing the need for novel insights and approaches. Long noncoding RNAs (lncRNAs) have emerged as key players in biological processes and influence gene expression regulation and cellular signalling pathways. This review explores the complex roles of lncRNAs in modulating chromatin function, regulating nuclear bodies, and impacting posttranslational modifications. Moreover, their interactions with various RNA species and proteins significantly influence cell signalling cascades, thereby contributing to diverse pathophysiological conditions, including cancer, neurological disorders, metabolic syndromes, and autoimmune diseases. We highlight the potential of lncRNAs as diagnostic biomarkers and therapeutic targets in clinical settings. By describing the complex involvement of lncRNAs in disease mechanisms, this review aims to stimulate further research in this field, encouraging a deeper understanding of disease pathogenesis and paving the way for innovative therapeutic strategies.
Ramesh, Palaniappan, Muthyala, Pallavi, Kali, Suresh Kumar. Deciphering the enigma: long noncoding RNAs in disease pathogenesis and therapeutic prospects. // Molecular and Cellular Biochemistry. – 2025. – DOI: 10.1007/s11010-025-05368-y. – URL: http://link.springer.com/openurl/fulltext?id=doi:10.1007/s11010-025-05368-y
Ramesh, Palaniappan, Muthyala, Pallavi, Kali, & Suresh Kumar (2025). Deciphering the enigma: long noncoding RNAs in disease pathogenesis and therapeutic prospects. Molecular and Cellular Biochemistry. https://doi.org/10.1007/s11010-025-05368-y
Ramesh, et al. “Deciphering the enigma: long noncoding RNAs in disease pathogenesis and therapeutic prospects.” Molecular and Cellular Biochemistry, 2025. doi:10.1007/s11010-025-05368-y.
@article{Ramesh2025,
title = {Deciphering the enigma: long noncoding RNAs in disease pathogenesis and therapeutic prospects},
author = {Ramesh and Palaniappan and Muthyala and Pallavi and Kali and Kumar, Suresh},
journal = {Molecular and Cellular Biochemistry},
year = {2025},
doi = {10.1007/s11010-025-05368-y},
url = {http://link.springer.com/openurl/fulltext?id=doi:10.1007/s11010-025-05368-y}
}
Large extracellular vesicles (lEVs) are heterogeneous structures with sizes that exceed 200 nm. Unlike small extracellular vesicles, which originate from either the endosomal system or the plasma membrane, most lEVs stem directly from...
Chaperone-mediated autophagy (CMA), the first-described selective lysosomal degradation pathway, is distinguished from other degradative pathways by the unique mechanism by which substrates reach the lysosomal lumen: CMA relies on a...
This Review focuses on the choice between homologous recombination and non-homologous end joining in DNA double-strand break repair. The antagonistic roles of 53BP1 and BRCA1–BARD1, the contribution of RNA–DNA hybrids and implications...
A 2010 paper identified PRDM9 as the sequence-specific regulator of meiotic recombination hotspots, showing it co-evolves with its rapidly changing binding motifs.
Genome editing is maturing from a one-size-fits-all system into a highly specialized ecosystem that includes a dizzying array of tools. In this Comment, we discuss the current and future use of Cas-induced homology-directed repair for...